Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-02-18Clinical Trial Update: Coronary Heart Disease Risk Factors in Upwardly Mobile Blacks and Whites
A completed NHLBI-sponsored clinical trial evaluating risk factors for coronary heart disease in upwardly mobile Black and White populations…
-
CLINICAL_TRIALS research · 2016-02-18Clinical Trial Update: Segregation/Linkage Analysis for Hypertension
A completed clinical trial (NCT00005158) from NHLBI focusing on segregation/linkage analysis for hypertension; no specific treatment results…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: End-organ Pathology in Childhood Essential Hypertension
An NHLBI-sponsored clinical trial investigating end-organ pathology in childhood essential hypertension has completed.
-
CLINICAL_TRIALS research · 2016-02-18Clinical Trial Update: Effect of Aerobic Exercise on Blood Pressure Changes [NA]
A National Heart, Lung, and Blood Institute–funded clinical trial examining how aerobic exercise affects blood pressure has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Charleston Heart Study - Predictors of Coronary Disease in Blacks
A completed clinical study from the Charleston Heart Study investigates predictors of coronary disease in Black participants. The update ind…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Insulin and Biogenic Amines in Cardiovascular Disease
A completed clinical trial update examining the role of insulin and biogenic amines in cardiovascular diseases, including hypertension, obes…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago
A completed NHLBI epidemiology study in Chicago evaluating cardiovascular and non-cardiovascular risk factors.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: PREMIER: Lifestyle Interventions for Blood Pressure Control [Phase 3]
Phase 3 clinical trial update for PREMIER lifestyle interventions to control blood pressure; the study has completed.
-
CLINICAL_TRIALS research · 2016-02-18Clinical Trial Update: Cardiovascular Disease in Black Versus White Physicians
A completed clinical trial update examining cardiovascular disease in Black versus White physicians.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: IN CONTROL--Hypertension Reduction in Inner City Seattle
The IN CONTROL trial investigating hypertension reduction in inner-city Seattle has completed; the snippet does not include trial results.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Hypertension in Families of African Origin
This is a completed NHLBI-sponsored clinical trial update examining hypertension in families of African origin; the study status is listed a…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Biobehavioral Mechanisms of Blood Pressure Regulation
A completed NHLBI-funded clinical trial update examining biobehavioral mechanisms of blood pressure regulation. The study addresses hyperten…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Opioid Compromise in Hypertension--Modulating Factors
A completed NHLBI-sponsored clinical trial investigates factors that modify the interaction between opioids and hypertension.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Stepped Intervention for Meds Adherence and Blood Pressure Control [NA]
This clinical trial update notes the completion of a stepped intervention aimed at improving medication adherence and blood pressure control…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Stress Reduction and Atherosclerotic CVD in Blacks [Phase 3]
Phase 3 trial studying stress reduction in atherosclerotic cardiovascular disease among Black participants has completed. The update notes c…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Improving Adherence to Interventions for Hypertension
This completed clinical trial update outlines efforts to improve adherence to hypertension interventions, sponsored by NHLBI.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Stress Reduction and Prevention of Hypertension in Blacks
Sponsored by NHLBI, the study on stress reduction to prevent hypertension in Black adults has completed.
-
CLINICAL_TRIALS research · 2016-02-18Clinical Trial Update: Race, Class, and Gender--Studies of Health Effects
A completed NHLBI study update examining health effects across race, class, and gender in cardiovascular conditions.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Serum Total Homocysteine and C-Reactive Protein - Ancillary to IDNT
This is an ancillary analysis of the IDNT trial, reporting serum total homocysteine and C-reactive protein measurements in participants with…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Evaluation of Childhood Blood Pressure and Lipid Screening
Completed clinical trial evaluating screening for blood pressure and lipids in children. The study assessed pediatric screening for cardiova…
-
FDA approval · 2016-02-16FDA Approved: RAMIPRIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for Ramipril (generic ACE inhibitor) under ANDA 077626, enabling a generic …
-
FDA approval · 2016-02-16FDA Approved: CAPTOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' supplemental application for CAPTOPRIL (captopril) under an existing ANDA. The action confirms continue…
-
FDA approval · 2016-02-16FDA Approved: QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental ANDA for quinapril hydrochloride/hydrochlorothiazide from Aurobindo Pharma Limited. The product is a generic ant…
-
FDA approval · 2016-02-12FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for the fixed-dose combination of benazepril hydrochloride and hydrochlorothiazide from Padagis …
-
FDA approval · 2016-02-12FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approves a supplemental application for EXFORGE HCT (amlodipine, valsartan, and hydrochlorothiazide) from Novartis Pharmaceuticals C…